The purpose of this ordinance is to determine the rates and fees for regulatory services offered on drugs and other health products by the drug regulatory authority for Burundi (ABREMA).
This Decree approves the amended statutes of the Beninese pharmaceutical regulatory agency, now named “Beninese Agency for Medicines and other Health Products”.
Arrêté N°2023-593 portant liste nationale des médicaments essentiels et autres produits de santé au Burkina Faso
This order establishes the essential medicines list; this list is revised every three years (article 10).
The purpose of this ordinance is to organize the registration of medicines for human use and other pharmaceutical inputs in Burundi.
This regulation is issued to implement the Food and Medicine Administration Proclamation No.1112/2019. It provides the organization, powers and duties of the Ethiopian Food and Drug Authority.
This decree, taken in application of the provisions of articles 22, 29 and 30 of Law No. 20/2005 of January 3, 2006, provides for the creation, attributions, organization and operation of the Public Health Emergency Operations Center in the Gabonese Republic, abbreviated to COUSP.
The Decree sets out the statutes of the Nigerian Pharmaceutical Regulatory Agency.
This Decree establishes and fixes the rules of organization and operation of the Senegalese Pharmaceutical Regulatory Agency (ARP)
The decree provides the modalities for establishing the list of essential medicines. It was published in the Official Journal of 31 May 2021 (pages 12 -13).
The Decree approves the National List of Essential Medicines.
The law creates the Burundian Authority for the Regulation of Medicines for Human Use and Food. The authority's general aim is to protect public health by promoting the quality and safety of products such as prefabricated and ambient foods, medicines for human use, cosmetics and dietary products containing active ingredients, herbal medicines, traditional medicines, and medical devices, among others.
The decree provides for the organization and functioning of the Central Purchasing Center for Essential Medicines of Burundi [CAMEBU].
Public health (Covid 19) (Risk determination and Mitigation measures) (N°5) Regulations, 2021
The document has the regulation taken by Lesotho’s government during the emergency of COVID 19.
Décret No 2021-279/PRN/MSP/O/AS du 29 avril 2021, adoptant la Politique Pharmaceutique Nationale
The Decree adopts the national pharmaceutical policy. This policy sets out and prioritizes the medium- and long-term goals set by the State for the pharmaceutical sector, and defines the main strategies for achieving them. It provides a framework within which pharmaceutical sector activities are coordinated. It covers both the public and private sectors, and involves all the main players in the pharmaceutical sector. It is an integral part of national health policy.
The Regulation sets up rules in the registration of drugs and related products manufactured, imported, exported, advertised, sold, distributed or used in Nigeria.
The order of 11 Joumada El Oula 1442 corresponding to 26 December 2020 lays down the procedure for setting the prices of medicinal products by the intersectoral economic committee for medicinal products. The text of this order was published in the official journal of 27 December 2020 (see pages 33-36).
The order establishes the national list of essential medicines and other health products in Burkina Faso.
This Order provides for the creation of the Centre de Coordination des Opérations d'Urgences de Santé abbreviated to ‘CCOUSP’ (coordination center for health emergency operations).
This Decree declares the State of Health Emergency and dictates precautionary measures for the prevention, containment and control of the new coronavirus pandemic in the Republic of Equatorial Guinea.
The document contains regulation taken by Lesotho’s government during the emergency of COVID 19.